Cargando…

Bone structure and remodelling in stroke patients: Early effects of zoledronate()

INTRODUCTION: We have reported that after an acute stroke, intravenous zoledronate prevented bone loss in the hemiplegic hip. Participants from the trial also volunteered for trans-iliac bone biopsy, to assess the early effects of stroke and zoledronate on iliac bone remodelling. METHODS: Patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poole, Kenneth E.S., Vedi, Shobna, Debiram, Irene, Rose, Collette, Power, Jon, Loveridge, Nigel, Warburton, Elizabeth A., Reeve, Jonathan, Compston, Juliet
Formato:	Texto
Lenguaje:	English
Publicado:	Elsevier Science 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724102/ https://www.ncbi.nlm.nih.gov/pubmed/19121416 http://dx.doi.org/10.1016/j.bone.2008.11.017

Ejemplares similares

Age-Related Changes in Bone Remodelling and Structure in Men: Histomorphometric Studies
por: Compston, Juliet
Publicado: (2011)

Dietary nitrate improves jaw bone remodelling in zoledronate‐treated mice
por: Pan, Wen, et al.
Publicado: (2023)

Skeletal Site-specific Effects of Zoledronate on in vivo Bone Remodeling and in vitro BMSCs Osteogenic Activity
por: Gong, Xue, et al.
Publicado: (2017)

The fragile elderly hip: Mechanisms associated with age-related loss of strength and toughness()
por: Reeve, Jonathan, et al.
Publicado: (2014)

Negative effect of zoledronic acid on tendon-to-bone healing: In vivo study of biomechanics and bone remodeling in a rat model
por: Hjorthaug, Geir Aasmund, et al.
Publicado: (2018)

The effect of zoledronate during bone healing
por: Matos, Marcos Almeida, et al.
Publicado: (2010)

Effects of Zoledronic Acid on Physiologic Bone Remodeling of Condylar Part of TMJ: A Radiologic and Histomorphometric Examination in Rabbits
por: Tatli, Ufuk, et al.
Publicado: (2014)

Bone Morphogenetic Protein 2 Promotes Bone Formation in Bone Defects in Which Bone Remodeling Is Suppressed by Long-Term and High-Dose Zoledronic Acid
por: Moon, Young Jae, et al.
Publicado: (2023)

Zoledronic acid in the management of metastatic bone disease
por: Polascik, Thomas J, et al.
Publicado: (2008)

Zoledronic Acid Preserves Bone Structure and Increases Survival but Does Not Limit Tumour Incidence in a Prostate Cancer Bone Metastasis Model
por: Hung, Tzong-Tyng, et al.
Publicado: (2011)

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases
por: LI, FENQIANG, et al.
Publicado: (2014)

Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
por: Lambrinoudaki, Irene, et al.
Publicado: (2008)

Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone
por: Giveon, Sharon, et al.
Publicado: (2023)

Cancer Treatment Dosing Regimens of Zoledronic Acid Result in Near-Complete Suppression of Mandible Intracortical Bone Remodeling in Beagle Dogs
por: Allen, Matthew R, et al.
Publicado: (2010)

Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats
por: Åstrand, Jörgen, et al.
Publicado: (2006)

Controlled Delivery of Zoledronate Improved Bone Formation Locally In Vivo
por: Gou, Wenlong, et al.
Publicado: (2014)

Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62(P394L) mouse model of Paget's disease
por: Daroszewska, Anna, et al.
Publicado: (2018)

Glucocorticoid-induced osteoporosis: an update
por: Compston, Juliet
Publicado: (2018)

Prevention and Treatment of Osteoporosis: Clinical Guidelines and New Evidence
por: Compston, Juliet
Publicado: (2000)

Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone
por: Cronin, Owen, et al.
Publicado: (2019)

Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture
por: Magaziner, Jay S, et al.
Publicado: (2014)

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
por: Aft, Rebecca
Publicado: (2012)

Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer
por: Akoury, Elie, et al.
Publicado: (2019)

Zoledronic acid for prevention of bone loss in patients receiving bariatric surgery
por: Liu, Yi, et al.
Publicado: (2021)

Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab
por: Park, Jung-Wee
Publicado: (2021)

Effect of Acetazolamide and Zoledronate on Simulated High Altitude-Induced Bone Loss
por: Brent, Mikkel Bo, et al.
Publicado: (2022)

Zoledronate combined metal-organic frameworks for bone-targeting and drugs deliveries
por: Pan, Yixiao, et al.
Publicado: (2022)

Zoledronic Acid Implant Coating Results in Local Medullary Bone Growth
por: Quarterman, Juliana C., et al.
Publicado: (2022)

Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
por: Xie, Jipan, et al.
Publicado: (2011)

Evaluation of zoledronate for the treatment of canine stage III osteosarcoma: A phase II study
por: Smith, Ashley A., et al.
Publicado: (2022)

Focal osteoporosis defects play a key role in hip fracture
por: Poole, Kenneth E.S., et al.
Publicado: (2017)

Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass
por: Hamdy, Ronald C
Publicado: (2010)

The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis
por: Hadji, P., et al.
Publicado: (2012)

Guided bone regeneration with local zoledronic acid and titanium barrier: An experimental study
por: Dundar, Serkan, et al.
Publicado: (2016)

Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases
por: Quattrocchi, Carlo C., et al.
Publicado: (2012)

Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty
por: Hsu, Allen Herng Shouh, et al.
Publicado: (2022)

Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption
por: Huang, Yanjuan, et al.
Publicado: (2020)

Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions
por: George, Christopher N., et al.
Publicado: (2020)

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
por: Brubaker, Kristen D, et al.
Publicado: (2006)

Zoledronic acid protects from local and systemic bone loss in TNF-mediated arthritis
por: Zwerina, J, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_ltgdjn0ji6itao6vui5cijra91